According to Bristol-Myers Squibb's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 2.27453. At the end of 2023 the company had a P/S ratio of 2.70.
Year | P/S ratio | Change |
---|---|---|
2023 | 2.70 | -18.58% |
2022 | 3.31 | 11.08% |
2021 | 2.98 | -9.5% |
2020 | 3.30 | -39.73% |
2019 | 5.47 | 46.19% |
2018 | 3.74 | -22.49% |
2017 | 4.83 | -3.97% |
2016 | 5.03 | -27.14% |
2015 | 6.90 | 12.28% |
2014 | 6.15 | 15.44% |
2013 | 5.32 | 76.57% |
2012 | 3.01 | 7.25% |
2011 | 2.81 | 21.74% |
2010 | 2.31 | 0.64% |
2009 | 2.29 | 4.12% |
2008 | 2.20 | -18.56% |
2007 | 2.71 | -6.14% |
2006 | 2.88 | 23.12% |
2005 | 2.34 | -9.03% |
2004 | 2.57 | -3.07% |
2003 | 2.66 | 2.56% |
2002 | 2.59 | -49.74% |
2001 | 5.15 |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
![]() Johnson & Johnson JNJ | 4.18 | 83.75% | ๐บ๐ธ USA |
![]() Novartis NVS | 3.81 | 67.48% | ๐จ๐ญ Switzerland |
![]() Pfizer PFE | 2.40 | 5.36% | ๐บ๐ธ USA |
![]() AbbVie ABBV | 4.63 | 103.52% | ๐บ๐ธ USA |
![]() Eli Lilly LLY | 17.4 | 665.37% | ๐บ๐ธ USA |
![]() Amgen AMGN | 5.40 | 137.52% | ๐บ๐ธ USA |
![]() Sanofi SNY | 2.37 | 4.01% | ๐ซ๐ท France |
![]() Biogen BIIB | 3.33 | 46.34% | ๐บ๐ธ USA |
![]() Merck MRK | 4.54 | 99.53% | ๐บ๐ธ USA |
![]() AstraZeneca AZN | 4.41 | 93.88% | ๐ฌ๐ง UK |